Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Inspiremd Inc (NSPR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,862
  • Shares Outstanding, K 1,358
  • Annual Sales, $ 3,600 K
  • Annual Income, $ -7,240 K
  • 60-Month Beta 1.96
  • Price/Sales 1.38
  • Price/Cash Flow N/A
  • Price/Book 0.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -2.00
  • Number of Estimates 1
  • High Estimate -2.00
  • Low Estimate -2.00
  • Prior Year -7.50
  • Growth Rate Est. (year over year) +73.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.00 +19.33%
on 06/06/19
4.12 -13.11%
on 05/29/19
+0.31 (+9.48%)
since 05/17/19
3-Month
3.00 +19.33%
on 06/06/19
8.43 -57.53%
on 04/01/19
-4.42 (-55.25%)
since 03/18/19
52-Week
3.00 +19.33%
on 06/06/19
52.75 -93.21%
on 06/20/18
-48.92 (-93.18%)
since 06/18/18

Most Recent Stories

More News
InspireMD to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 14

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it...

NSPR : 3.58 (-1.92%)
InspireMD, Inc. Announces Pricing of $2.4 Million Public Offering of Common Stock

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced the pricing...

NSPR : 3.58 (-1.92%)
InspireMD, Inc. Announces Proposed Public Offering of Common Stock

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that it...

NSPR : 3.58 (-1.92%)
Thinking about buying stock in Cronos Group Inc., Facebook Inc., InspireMD Inc., Pulmatrix Inc., or Sangamo Therapeutics?

InvestorsObserver issues critical PriceWatch Alerts for CRON, FB, NSPR, PULM, and SGMO.

SGMO : 9.91 (+1.54%)
NSPR : 3.58 (-1.92%)
PULM : 0.98 (+2.27%)
FB : 188.47 (-0.29%)
InspireMD Announces 1-for-50 Reverse Stock Split

InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR.WSB), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that its Board of Directors...

NSPR : 3.58 (-1.92%)
InspireMD Provides Amended Disclosure

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today provided an amended...

NSPR : 3.58 (-1.92%)
InspireMD to Report Fourth Quarter and Fiscal 2018 Financial Results and Provide Business Update on Tuesday, February 19

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it...

NSPR : 3.58 (-1.92%)
InspireMD Announces Two Successful Live Clinical Case Transmissions Featuring CGuard(TM) EPS at the Leipzig Interventional Course (LINC) 2019

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that two...

NSPR : 3.58 (-1.92%)
InspireMD Announces Results from Initial Clinical Study of The CGuard(TM) Embolic Prevention System (EPS) with SmartFit(TM) Technology

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced details...

NSPR : 3.58 (-1.92%)
InspireMD's CGuard(TM) Embolic Prevention System to be Prominently Featured in Live Case Transmissions at LINC, 22nd to the 25th January 2019, in Leipzig, Germany

InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that its CGuard(TM) Carotid Embolic Prevention...

NSPR : 3.58 (-1.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade NSPR with:

Business Summary

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous...

See More

Key Turning Points

2nd Resistance Point 4.07
1st Resistance Point 3.82
Last Price 3.58
1st Support Level 3.40
2nd Support Level 3.23

See More

52-Week High 52.75
Fibonacci 61.8% 33.75
Fibonacci 50% 27.87
Fibonacci 38.2% 22.00
Last Price 3.58
52-Week Low 3.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar